authors
- Peled, N
- Rodriguez-Abreu, D
- Bordoni, R
- Ellis, Peter
- Hochmair, M
- Müller, V
- Levchenko, E
- Zhou, H
- Zhao, B
- Lara-Guerra, H
- Ahn, M-J
114TiP KEYNOTE-B99: Phase II study of pembrolizumab plus investigational agents combined with chemotherapy as first-line therapy for extensive-stage small cell lung cancer (ES-SCLC)
Conferences
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- December 2021
has subject area
- 1112 Oncology and Carcinogenesis (FoR)
- Oncology & Carcinogenesis (Science Metrix)
published in
- Annals of Oncology Journal
presented at event
- ESMO Immuno-Oncology Congres Conference